Louvain-la-Neuve, Belgium, 7 February 2019 – AuXin Surgery, a medical device company, announces that it has obtained CE Class III certification for its novel CADISS® System for the surgery of chronic otitis and epidural fibrosis.

PharmaFluidics NV is a game-changing innovator in the field of analytical chromatography. The company has devised a fundamentally new way of performing separations by creating nano-LC columns on a silicon chip. Their µPACTM columns enable a robust and highly reproducible detection of more molecules from complex biological samples such as biopsies, proteome digests, culture media or bio-pharmaceutical actives. Building upon their groundbreaking micro Pillar Array technology, a new trapping column was launched today, further improving analytical capabilities and throughput time of analyses with µPACTM columns.

19 November 2018 - Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES) to Launch First Global Assessment Report on Biodiversity and Ecosystem Services Since 2005

15 November 2018, Ghent (Belgium) - V-Bio Ventures leads Camel-IDS EUR 37m Series A financing to develop cancer targeted radiopharmaceuticals

14 Nov 2018 - Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces the completion of the Phase III Estelle® study in the US and Canada. Estelle® is Mithra’s novel combined oral contraceptive (COC), containing 15 mg Estetrol (E4)/ 3 mg drospirenone (DRSP). Top line data remain on track to be reported in Q1 2019.

11 October 2018 - Mithra (Euronext Brussels: MITRA), a Liège-based company dedicated to Women’s Health, provided an update on its key programmes at the CPHI world conference held yesterday. News was very positive, with the company reporting strong clinical and financial results.

1st October 2018 Cancer kills millions of people every year and is one of humanity’s greatest health challenges. By stimulating the inherent ability of our immune system to attack tumor cells this year’s Nobel Laureates have established an entirely new principle for cancer therapy.

7th September 2018 During the next few years, the faculties at Ghent University will more closely collaborate with each other in the realisation of ten interdisciplinary projects of major social impact. Ghent University is creating 21 new professorships which they will begin to fill as of this autumn.